NASDAQ:ONCS   OncoSec Medical Incorporated
When, I say that passion goes beyond the imagination, I am led back to this title, believe me, in many years of studies and research in the field of biotechnology, there have been many satisfactions compared to dispaires. Well if I told you that ONCS , in the second half of 2019 and in the first three months of 2020, will officially present TAVO to the world as a trade and product must by them final not only in Australia and New Zealand. but throughout the world as an elite melanoma treatment product, we will wonder if $ 30 per share, given the current RS , will be sufficient ...
If you want to give yourself a space gift, and you can wait, this will reward you at least 15 times in my opinion the current level.
Good trading at all.
PAY ATTENTION PLS .. allert in action


The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.